SATT logo
SATTTargeted Therapy

Symposium

A dedicated symposium on EGFR mutations in NSCLC, featuring updates on third-generation TKIs and resistance mechanisms.

October 1, 2026Symposium

Start date

October 1, 2026

End date

October 2, 2026

Location

Medical Education Hall, Example City, Example Country

Type

Symposium

Scientific Committee

Agenda

  1. October 1,EGFR Testing Best Practices

    Optimal strategies for EGFR testing in NSCLC.

  2. October 1,Third-Generation TKIs

    Osimertinib and emerging EGFR inhibitors.

  3. October 1,Resistance Mechanisms

    How EGFR resistance develops and how to overcome it.